Feasibility and safety of a reduced duration of therapy of colony-stimulating factor in a dose-dense regimen

PURPOSE: The risk of febrile neutropenia (FN) in cancer patients receiving chemotherapy is mainly due to the type of chemotherapy regimen and the presence of specific risk factors in patients. The recent trend of using a dose-dense treatment schedule has enhanced the risk of FN. In the present prosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Rigacci, Luigi, Puccini, Benedetta, Kovalchuk, Sofia, Fabbri, Elisa, Bonizzoni, Erminio, Perrone, Tania, Bosi, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4118033/
https://www.ncbi.nlm.nih.gov/pubmed/24740178
http://dx.doi.org/10.1007/s00520-014-2237-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4118033/
https://www.ncbi.nlm.nih.gov/pubmed/24740178
http://dx.doi.org/10.1007/s00520-014-2237-9

Ejemplares similares